Latanoprost ophthalmic solution 0.005% with 0.02% BAK or travoprost 0.004% ophthalmic solution with sofZia were tested against the following bacteria and fungi: Staphylococcus aureus (ATCC 6538 ...
Himani Goyal, MD, takes glaucoma care to the next level by embracing advancements that extend beyond traditional treatment ...
Hosted on MSN6mon
115,000 patients to get daily eye drops that stop them going blindBut the most common treatment is pressure-reducing eye drops, which are applied once or twice a day. These include low-strength drops, such as bimatoprost or latanoprost. If these do not work ...
Qlaris Bio, Inc., a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced positive topline results from two U.S. Phase II clinical trials ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results